<DOC>
	<DOCNO>NCT01197235</DOCNO>
	<brief_summary>The purpose study determine whether drug produce red blood cell effective prevention kidney dysfunction coronary angiography patient chronic kidney disease .</brief_summary>
	<brief_title>Effect Darbepoetin Contrast-induced Nephropathy</brief_title>
	<detailed_description>Use radiocontrast agent inevitable compute tomography angiography . However , contrast agent aggravate kidney function . Contrast-induced nephropathy ( CIN ) refer clinical situation decrease kidney function use contrast . CIN 3rd common cause acute kidney injury hospital . There lot report death rate increase patient CIN . Erythropoietin agent treat anemia . It also report tissue-protective effect animal experiment . In study , hypothesize erythropoietin reduce incidence CIN patient chronic kidney disease undergo coronary angiography .</detailed_description>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>age 18 yr estimate glomerular filtration rate ( GFR ) &lt; 60 ml/min/1.73m2 Chronic renal replacement therapy ( hemodialysis , peritoneal dialysis , continuous renal replacement therapy ) Pregnancy lactation Use contrast agent within 1 week Emergent CAG PCI Not recover AKI ( acute kidney injury ) Use nephrotoxic drug within 48 hr Cardiogenic shock ( SBP ( systolic blood pressure ) &lt; 90 mmHg ) pulmonary edema Uncontrolled hypertension ( SBP ≥ 200 mmHg DBP ( diastolic blood pressure ) ≥ 130 mmHg ) History hypersensitivity contrast agent Known allergy hypersensitivity EPO ( erythropoietin ) Use EPO within 1 month Anemia ( hemoglobin &lt; 9 g/dL ) Ventilatory care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>darbepoetin , chronic kidney disease , coronary angiography</keyword>
</DOC>